Skip to main content
Article
Evidence-Based Acute Bronchitis Therapy
Journal of Pharmacy Practice
  • Kimberly L Barefield, Philadelphia College of Osteopathic Medicine
  • Aaron Atkins
Document Type
Article
Publication Date
1-1-2012
Abstract

Acute bronchitis is a disease characterized by inflammation of the large airways within the lung accompanied by a cough lasting from 1 to 3 weeks. The inflammation occurs as a result of an airway infection or environmental trigger, with viral infections accounting for an estimated 89% to 95% of cases. Symptomatic treatment of cough is primarily required for patients, though in most cases the condition is self-limiting. Therapy consists of both nonpharmacological and pharmacological options to include antibiotics and antivirals, antitussive agents, protussive agents, and beta-2-agonists. This article reviews the treatment options for acute bronchitis and recommends criteria for use.

Comments

This article was published in Journal of Pharmacy Practice, Volume 25, Issue 6, Pages 586-590.

The published version is available at https://doi.org/10.1177/0897190012460826.

Copyright © 2012.

Citation Information
Kimberly L Barefield and Aaron Atkins. "Evidence-Based Acute Bronchitis Therapy" Journal of Pharmacy Practice Vol. 25 Iss. 6 (2012) p. 586 - 590
Available at: http://works.bepress.com/kimberly-barefield/31/